Literature DB >> 19343273

Eel calcitonin (elcatonin) suppressed callus remodeling but did not interfere with fracture healing in the femoral fracture model of cynomolgus monkeys.

Takeshi Manabe1, Satoshi Mori, Tasuku Mashiba, Yongping Cao, Yoshio Kaji, Ken Iwata, Satoshi Komatsubara, Tetsuji Yamamoto, Azusa Seki, Hiromichi Norimatsu.   

Abstract

We investigated the effect of eel calcitonin (elcatonin) on the process of fracture repair in the osteotomized femur of cynomolgus monkeys, since they possess a Haversian remodeling system similar to that of humans. Alendronate was used for comparison. Twenty female cynomolgus monkeys (Macaca fascicularis), aged 18-22 years, were allocated into five groups: control (CNT, n = 4), low-dose elcatonin group (0.5 U/kg; ELL, n = 4), high-dose elcatonin group (5 U/kg; ELH, n = 4), low-dose alendronate group (10 microg/kg; ALL, n = 4) and high-dose alendronate group (100 microg/kg; ALH, n = 4). All animals were given subcutaneous injections twice a week for 3 weeks. Then fracture was produced surgically by transversely cutting the midshaft of the right femur and fixing with stainless steel plate. After fracture, treatments were continued until sacrifice at 26 weeks after surgery. The femora were assessed by micro CT, contact microradiograph, three-point bending mechanical test and histomorphometry. Micro CT showed that callus sizes in elcatonin-treated groups were similar to CNT, whereas alendronate-treated groups had larger calluses than those in the CNT and elcatonin-treated groups. Fracture lines almost disappeared in the CNT and elcatonin-treated groups but remained clear in the alendronate-treated groups. Total area did not differ significantly between the elcatonin-treated groups and the CNT but was significantly greater in the ALH compared to the CNT and elcatonin-treated groups, due to increased callus area in the ALH group. Callus remodeling was less suppressed in the elcatonin-treated groups than in the alendronate-treated groups when compared with callus remodeling in the CNT. Although no significant differences in structural mechanical properties such as ultimate load, stiffness and work to failure were found among all groups, ultimate stress was significantly reduced in the ALH group compared with CNT and ELL groups. In conclusion, mild suppression of callus remodeling by elcatonin did not impair overall fracture healing process. In contrast, alendronate delayed structural fracture healing process by strongly suppressing callus remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343273     DOI: 10.1007/s00774-009-0046-x

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  29 in total

Review 1.  Can bisphosphonates be given to patients with fractures?

Authors:  H Fleisch
Journal:  J Bone Miner Res       Date:  2001-03       Impact factor: 6.741

Review 2.  Therapeutic approaches to bone diseases.

Authors:  G A Rodan; T J Martin
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

3.  Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats.

Authors:  J Li; S Mori; Y Kaji; J Kawanishi; T Akiyama; H Norimatsu
Journal:  J Bone Miner Res       Date:  2000-10       Impact factor: 6.741

Review 4.  Bisphosphonates: mechanisms of action.

Authors:  G A Rodan; H A Fleisch
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

5.  Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization.

Authors:  G C Nicholson; J M Moseley; P M Sexton; F A Mendelsohn; T J Martin
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 6.  The biology of fracture healing in long bones.

Authors:  B McKibbin
Journal:  J Bone Joint Surg Br       Date:  1978-05

7.  Comparison of antiresorptive activities of ipriflavone, an isoflavone derivative, and elcatonin, an eel carbocalcitonin.

Authors:  T Fujita; Y Fujii; A Miyauchi; Y Takagi
Journal:  J Bone Miner Metab       Date:  1999       Impact factor: 2.626

8.  A clinical trial on the effects of a combination of elcatonin (carbocalcitonin) and conjugated estrogens on vertebral bone mass in early postmenopausal women.

Authors:  M Meschia; M Brincat; P Barbacini; P G Crossignani; W Albisetti
Journal:  Calcif Tissue Int       Date:  1993-07       Impact factor: 4.333

9.  Histochemical and autoradiographic studies on elcatonin internalization and intracellular movement in osteoclasts.

Authors:  M Ikegame; S Ejiri; H Ozawa
Journal:  J Bone Miner Res       Date:  1994-01       Impact factor: 6.741

10.  Expression cloning of an adenylate cyclase-coupled calcitonin receptor.

Authors:  H Y Lin; T L Harris; M S Flannery; A Aruffo; E H Kaji; A Gorn; L F Kolakowski; H F Lodish; S R Goldring
Journal:  Science       Date:  1991-11-15       Impact factor: 47.728

View more
  8 in total

1.  Effect of dosing interval duration of intermittent ibandronate treatment on the healing process of femoral osteotomy in a rat fracture model.

Authors:  Takeshi Manabe; Satoshi Mori; Tasuku Mashiba; Yoshio Kaji; Ken Iwata; Satoshi Komatsubara; Tetsuji Yamamoto
Journal:  Calcif Tissue Int       Date:  2012-01-17       Impact factor: 4.333

2.  Elcatonin attenuates disuse osteoporosis after fracture fixation of tubular bone in rats.

Authors:  Zhe Ji; Chao Shi; Shengli Huang; Xiaoqian Dang; Kunzheng Wang; Binshang Lan
Journal:  J Orthop Surg Res       Date:  2015-07-03       Impact factor: 2.359

3.  Bone augmentation using a new injectable bone graft substitute by combining calcium phosphate and bisphosphonate as composite--an animal model.

Authors:  Carsten W Schlickewei; Georg Laaff; Anne Andresen; Till O Klatte; Johannes M Rueger; Johannes Ruesing; Matthias Epple; Wolfgang Lehmann
Journal:  J Orthop Surg Res       Date:  2015-07-25       Impact factor: 2.359

4.  Do bisphosphonates affect bone healing? A meta-analysis of randomized controlled trials.

Authors:  Deting Xue; Fangcai Li; Gang Chen; Shigui Yan; Zhijun Pan
Journal:  J Orthop Surg Res       Date:  2014-06-05       Impact factor: 2.359

5.  Stress fractures of the foot and ankle in athletes.

Authors:  Stephanie W Mayer; Patrick W Joyner; Louis C Almekinders; Selene G Parekh
Journal:  Sports Health       Date:  2014-11       Impact factor: 3.843

6.  An appropriate Wnt/β-catenin expression level during the remodeling phase is required for improved bone fracture healing in mice.

Authors:  Quanwei Bao; Sixu Chen; Hao Qin; Jianquan Feng; Huayu Liu; Daocheng Liu; Ang Li; Yue Shen; Yufeng Zhao; Junfeng Li; Zhaowen Zong
Journal:  Sci Rep       Date:  2017-06-02       Impact factor: 4.379

7.  Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis?

Authors:  Leila Kolios; Ann Kristin Hoerster; Stephan Sehmisch; Marie Christin Malcherek; Thomas Rack; Mohammed Tezval; Dana Seidlova-Wuttke; Wolfgang Wuttke; Klaus Michael Stuermer; Ewa Klara Stuermer
Journal:  Calcif Tissue Int       Date:  2009-12-01       Impact factor: 4.333

8.  Initial non-weight-bearing therapy is important for preventing vertebral body collapse in elderly patients with clinical vertebral fractures.

Authors:  Yoichi Kishikawa
Journal:  Int J Gen Med       Date:  2012-04-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.